TherapeuticsMD, Inc. (TXMD)
NASDAQ: TXMD · Real-Time Price · USD
1.370
+0.040 (3.01%)
At close: Nov 22, 2024, 4:00 PM
1.420
+0.050 (3.65%)
After-hours: Nov 22, 2024, 4:00 PM EST
TherapeuticsMD Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | -3.32 | -10.28 | 112 | -172.42 | -183.52 | -176.15 | Upgrade
|
Depreciation & Amortization | 0.25 | 0.12 | 1.19 | 0.74 | 4.07 | 1.39 | Upgrade
|
Other Amortization | - | - | - | - | 2.53 | 0.86 | Upgrade
|
Asset Writedown & Restructuring Costs | 1.7 | 0.5 | - | - | 1.13 | 0.08 | Upgrade
|
Stock-Based Compensation | 0.36 | 1.27 | 11.57 | 18.13 | 10.68 | 10.68 | Upgrade
|
Provision & Write-off of Bad Debts | - | - | - | - | 0.24 | 0.32 | Upgrade
|
Other Operating Activities | -0.73 | 2.45 | -111.32 | 93.83 | 8.75 | 11.13 | Upgrade
|
Change in Accounts Receivable | - | - | - | - | -8.22 | -13.65 | Upgrade
|
Change in Inventory | - | - | - | - | -3.34 | -8.59 | Upgrade
|
Change in Accounts Payable | -0.46 | -2.14 | -1.21 | -1.06 | 1.89 | -3.56 | Upgrade
|
Change in Other Net Operating Assets | -1.9 | -15.31 | -2.88 | 5.65 | 6.33 | 11.78 | Upgrade
|
Operating Cash Flow | -7.12 | -48.14 | -4.08 | -142.69 | -159.47 | -165.72 | Upgrade
|
Capital Expenditures | - | - | - | -0.03 | -0.21 | -2.45 | Upgrade
|
Sale (Purchase) of Intangibles | - | - | -0.36 | -2.19 | -1.39 | -21.44 | Upgrade
|
Other Investing Activities | - | - | 223.83 | - | - | - | Upgrade
|
Investing Cash Flow | - | - | 223.48 | -2.22 | -1.6 | -23.89 | Upgrade
|
Long-Term Debt Issued | - | - | - | - | 50 | 200 | Upgrade
|
Total Debt Issued | - | - | - | - | 50 | 200 | Upgrade
|
Long-Term Debt Repaid | - | - | -219.43 | -50 | - | -81.66 | Upgrade
|
Total Debt Repaid | - | - | -219.43 | -50 | - | -81.66 | Upgrade
|
Net Debt Issued (Repaid) | - | - | -219.43 | -50 | 50 | 118.34 | Upgrade
|
Issuance of Common Stock | 2 | 3.15 | 2.47 | 184.67 | 31.98 | 77.14 | Upgrade
|
Other Financing Activities | - | - | -1.27 | -5.12 | -1.25 | -6.65 | Upgrade
|
Financing Cash Flow | 2 | 3.15 | -235.21 | 129.55 | 80.73 | 188.83 | Upgrade
|
Net Cash Flow | -5.12 | -44.99 | -15.81 | -15.36 | -80.34 | -0.78 | Upgrade
|
Free Cash Flow | -7.12 | -48.14 | -4.08 | -142.73 | -159.68 | -168.17 | Upgrade
|
Free Cash Flow Margin | -446.18% | -3697.47% | -5.83% | -5547.10% | -246.14% | -338.73% | Upgrade
|
Free Cash Flow Per Share | -0.62 | -4.61 | -0.44 | -17.93 | -28.96 | -34.13 | Upgrade
|
Cash Interest Paid | - | - | 13.55 | 25.07 | 25.85 | 17.79 | Upgrade
|
Levered Free Cash Flow | -10.92 | -34.19 | 38.54 | -28.46 | -93.54 | -128.28 | Upgrade
|
Unlevered Free Cash Flow | -10.92 | -34.19 | 38.54 | -28.46 | -78.21 | -118.27 | Upgrade
|
Change in Net Working Capital | 8.53 | 30.25 | -19.47 | 0.37 | -5.15 | 12 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.